CRIPPA VALENTINA

(2024). Characterizing Molecular Pathways and Therapeutic Prospects in MDS/MPN Neoplasms: A Focus on SETBP1 Mutations. (Tesi di dottorato, Università degli Studi di Milano-Bicocca, 2024). Dettaglio

Crippa, V., Fina, E., Ramazzotti, D., Piazza, R. (2024). Control-FREEC viewer: a tool for the visualization and exploration of copy number variation data. BMC BIOINFORMATICS, 25(1) [10.1186/s12859-024-05694-w]. Dettaglio

Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD [10.1182/blood.2023021349]. Dettaglio

Aroldi, A., Angaroni, F., D’Aliberti, D., Spinelli, S., Crespiatico, I., Crippa, V., et al. (2023). Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples. VIRUSES, 15(1) [10.3390/v15010007]. Dettaglio

Fontana, D., Crespiatico, I., Crippa, V., Malighetti, F., Villa, M., Angaroni, F., et al. (2023). Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients. NATURE COMMUNICATIONS, 14(1) [10.1038/s41467-023-41670-3]. Dettaglio